Trials / Completed
CompletedNCT00701844
Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 315 (actual)
- Sponsor
- University of North Carolina, Chapel Hill · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Sharing Our Strength study is being conducted to help us understand people's experiences with hematopoietic stem cell transplantation and to test a new program designed to help people recover physically and emotionally after transplant.
Detailed description
This is a study for survivors of hematopoietic stem cell transplantation (also known as bone marrow transplant), which is an intensive medical treatment for cancers such as leukemia, lymphoma, and multiple myeloma as well as other diseases. Because it is a physically and emotionally demanding treatment, many people report having ongoing physical and emotional difficulties after having a transplant. The Sharing Our Strength study is being conducted to help us understand people's transplant experiences and to test a new program designed to help them recover physically and emotionally after transplant. All parts of the study are completed by mail and telephone. Participants will receive compensation for their time.
Conditions
- Leukemia
- Acute Leukemia
- Acute Lymphocytic Leukemia
- Multiple Myeloma
- Hematological Cancers
- Psychological Distress
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Writing A (Experimental informative writing) | Experimental informative writing |
| BEHAVIORAL | Writing B (Experimental noninformative writing) | Experimental noninformative writing |
| BEHAVIORAL | Writing C (Control informative writing) | Control informative writing |
| BEHAVIORAL | Writing D (Control noninformative writing) | Control noninformative writing |
Timeline
- Start date
- 2007-07-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2008-06-19
- Last updated
- 2017-11-17
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00701844. Inclusion in this directory is not an endorsement.